107 related articles for article (PubMed ID: 1225309)
1. [Case of implantation of human fetal thymus on the immunological reactivity in patients with Hodgkin's disease].
Pekić B; Dujić A; Radojicić B; Radojicić C; Kolasinović N; Martinović N; Susaković N; Radovanović L
Bilt Hematol Transfuz; 1975; 3(1-2):105-19. PubMed ID: 1225309
[TBL] [Abstract][Full Text] [Related]
2. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
Fuks Z; Strober S; King DP; Kaplan HS
J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
[TBL] [Abstract][Full Text] [Related]
3. [Letter: Implantation of fetal thymus during the terminal period of Hodgkin's disease. Immunologic and histological data].
Lang JM; Oberling F; Lacroute JM; Mayer S; Brettes PH
Nouv Presse Med; 1975 Feb; 4(7):509. PubMed ID: 1079342
[No Abstract] [Full Text] [Related]
4. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
Land JM; Litwin J; Bigel P; Oberling F; Mayer S
Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
[TBL] [Abstract][Full Text] [Related]
5. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
6. [Effect of implantation of human embryonic thymus tissue in Hodgkin's disease].
Veskova TK; Lichinitser MR; Astrakhan VI; Svet-Moldavskiĭ GIa
Vopr Onkol; 1971; 17(8):58-61. PubMed ID: 5134101
[No Abstract] [Full Text] [Related]
7. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
8. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
9. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
[TBL] [Abstract][Full Text] [Related]
10. Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.
Amlot PL; Unger A
Clin Exp Immunol; 1976 Dec; 26(3):520-7. PubMed ID: 1009684
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte function in patients with Hodgkin's disease.
Rühl H; Vogt W; Rühl U
G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
[TBL] [Abstract][Full Text] [Related]
12. Thymus transplantation. Reconstitution of cellular immunity in a four-year-old patient with T-cell deficiency.
Businco L; Rezza E; Giunchi G; Aiuti F
Clin Exp Immunol; 1975 Jul; 21(1):32-38. PubMed ID: 171111
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary results of transplantation of thymus originating from patients with myasthenia gravis to patients with leukemia and those with Hodgkin's disease].
Rzepecki WM; Lukasiewicz M; Aleksandrowicz J; Szmigiel Z; Skotnicki A; Lisienicz J
Przegl Lek; 1973; 30(6):518-20. PubMed ID: 4732446
[No Abstract] [Full Text] [Related]
14. Quantitation of immunocompetence in Hodgkin's disease.
Faguet GB
J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
[TBL] [Abstract][Full Text] [Related]
15. [Electrophoretic mobility of peripheral lymphocytes and Hodgkin's erythrocytes. Correlation with some clinical, hematological and immunological parameters of the disease].
Tognella S; Mantovani G; Del Giacco GS; Floris C; Manconi PE; Grifoni V
Boll Ist Sieroter Milan; 1975; 54(6):480-6. PubMed ID: 769799
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease.
Lang JM; Oberling F; Bigel P; Mayer S; Waitz R
Biomedicine; 1974 Sep; 21(9):372-7. PubMed ID: 4281669
[No Abstract] [Full Text] [Related]
17. [Immunological aspects of Hodgkin's disease].
Bianchini E
Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
[TBL] [Abstract][Full Text] [Related]
18. Immune condition in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Traczyk Z; Pawelski S; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Karpowicz M; Małkowska-Zwierz W
Arch Immunol Ther Exp (Warsz); 1980; 28(1):153-60. PubMed ID: 6968189
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte function in Hodgkin's Disease.
Benninghoff DL; Girardet R
Lymphology; 1976 Mar; 9(1):39-42. PubMed ID: 1263573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
